Heading
Intro
Throne
Stem Cell Educator (Copy)
Stem Cell Educator Therapy
Stem Cell Educator
Type 1 Diabetes
Alopecia
COVID-19
Additional diseases
Journal Publications
Unrivaled Advantage
Timeline
News
Home
Overview
Diabetes
Alopecia Areata
Expanded Access
Research
Progress
Media
Team

Throne Biotechnologies

Heading
Intro
Throne
Stem Cell Educator (Copy)
Stem Cell Educator Therapy
Stem Cell Educator
Type 1 Diabetes
Alopecia
COVID-19
Additional diseases
Journal Publications
Unrivaled Advantage
Timeline
News
Home
Overview
Diabetes
Alopecia Areata
Expanded Access
Research
Progress
Media
Team
April 14, 2021
Throne Biotechnologies

Interview: 2 year type 1 diabetes patient follow up - blood sugar back to normal

April 14, 2021
Throne Biotechnologies

Aaron was only 13 years old when he underwent the Stem Cell Educator Therapy clinical trials in 2018. Hear what happened two and a half years later!

April 14, 2021
Throne Biotechnologies

Throne Biotechnologies

US FDA approves Stem Cell Educator Therapy for COVID-19 to begin phase 2 clinical trials
JDCA Names Stem Cell Educator Therapy Among World's Top 7 Practical Cures for T1D

Paramus, New Jersey - New York City Metro

connect@thronebio.com

Back To Top
 

Life is in

Throne logo mark - full color.png
 

the Blood

© 2025 Throne Biotechnologies Inc., All rights reserved.